Holen Sie sich die Stockscreener-App
42.81
0.33%
-0.14
Handel nachbörslich:
42.81
Artivion Inc Aktie (AORT) Neueste Nachrichten
Artivion's Strong Financials and Promising Pipeline Justify Buy Rating - AInvest
Artivion SVP Holloway sells $1m in shares after option exercise - Investing.com
Artivion SVP Holloway sells $1m in shares after option exercise By Investing.com - Investing.com South Africa
Artivion’s chief commercial officer Davis sells $471k in shares - Investing.com
Artivion Insider Sold Shares Worth $471,756, According to a Recent SEC Filing - MarketScreener
Chart based analysis of Artivion Inc. trends2025 Institutional Moves & Growth Focused Investment Plans - Newser
Earnings visualization tools for Artivion Inc.Weekly Volume Report & AI Driven Price Forecasts - Newser
Will Artivion Inc. stock benefit from interest rate changesPortfolio Value Summary & Daily Volume Surge Signals - Newser
Artivion stock hits 52-week high at 43.93 USD By Investing.com - Investing.com Australia
Artivion stock hits 52-week high at 43.93 USD - Investing.com India
Artivion at Canaccord Conference: Strategic Growth and Innovation - Investing.com
Is this a good reentry point in Artivion Inc.July 2025 Action & Daily Growth Stock Investment Tips - Newser
Artivion, Inc. (NYSE:AORT) Stock Holdings Lifted by Natixis Advisors LLC - Defense World
Artivion's (AORT) Buy Rating Reiterated at Needham & Company LLC - MarketBeat
Is now a turning point for Artivion Inc.IPO Watch & AI Driven Stock Reports - Newser
Can Artivion Inc. ride the EV wavePositive Outlook Long-Term Picks - kangso.co.kr
Revenues Tell The Story For Artivion, Inc. (NYSE:AORT) As Its Stock Soars 37% - simplywall.st
Artivion, Inc. (NYSE:AORT) Q2 2025 Earnings Call Transcript - Insider Monkey
Technical signs of recovery in Artivion Inc.Reversal Signal Prediction Based on Volume - Newser
Artivion Inc. Reports Strong Q2 Earnings and Positive Outlook - TipRanks
Artivion Appoints Lance Berry as COO, Raises Earnings Guidance - AInvest
Artivion Appoints Lance Berry as COO - MarketScreener
Artivion Appoints Lance A. Berry as COO - TipRanks
Artivion Reaches Analyst Target Price - Nasdaq
Artivion Shows Market Leadership With Jump To 93 RS Rating - Investor's Business Daily
Artivion Surges on Improved 2025 Financial Outlook - StocksToTrade
Artivion’s Stocks Surge as Q2 Financials Exceed Expectations - timothysykes.com
Artivion (NYSE:AORT) Earns “Buy” Rating from Needham & Company LLC - Defense World
Needham & Company LLC Reaffirms “Buy” Rating for Artivion (NYSE:AORT) - Defense World
Canaccord Genuity Group Forecasts Strong Price Appreciation for Artivion (NYSE:AORT) Stock - Defense World
What technical models suggest about Artivion Inc.’s comebackPredictive Short-Term Market Reversal Alerts - Newser
Artivion raises 2025 revenue guidance to $435M–$443M as On-X and stent grafts drive double-digit growth - MSN
Artivion's Q2 Earnings Surge: A High-Margin Medical Innovation Play with Undervalued Potential - AInvest
Artivion, Inc.'s (NYSE:AORT) 26% Jump Shows Its Popularity With Investors - 富途牛牛
Artivion price target raised to $45 from $32 at Needham - Yahoo Finance
Artivion Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Artivion Elevates 2025 Revenue Projection Amid Strong Q2 Earnings - StocksToTrade
A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $40 to $45 - 富途牛牛
Artivion 2025 Q2 Earnings Strong Performance with Net Income Surges 163% - AInvest
Artivion price target raised to $41 from $35 at Canaccord - MSN
Zurcher Kantonalbank Zurich Cantonalbank Raises Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion (NYSE:AORT) Shares Gap Up on Better-Than-Expected Earnings - Defense World
Is Artivion Inc. stock heavily shortedBest ROI Stock Strategies - thegnnews.com
Artivion (NYSE:AORT) Stock Rating Upgraded by Wall Street Zen - Defense World
Comparing Artivion Inc. in custom built stock radarsSector-Wise Equity Performance Trend Forecast - Newser
Artivion Inc. stock trend forecastFree Swing Trading Entry Point Signals - Newser
Artivion (AORT): Canaccord Genuity Raises Price Target to $41.00 - GuruFocus
Artivion: Canaccord Genuity Raises PT to $41 from $35, Maintains Buy Rating - AInvest
Artivion’s Surging Stock: Rising Star or Temporary Miracle? - timothysykes.com
A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $35 to $45 - 富途牛牛
Artivion (AORT): Accelerating Growth and Margin Expansion in a High-Margin Medical Device Niche - AInvest
Artivion Raises 2025 Revenue Guidance to $435M-$443M, Driven by On-X and Stent Grafts. - AInvest
Why Is Artivion (AORT) Stock Rocketing Higher Today - TradingView
Artivion, Inc. shares surge 19.02% intraday after strong Q2 earnings and raised sales forecast. - AInvest
Artivion: JMP Securities Raises PT to $42 from $33, Maintains Market Outperform - AInvest
Artivion, Inc. shares surge 19.36% intraday after positive analyst ratings, strong Q2 earnings, and raised 2025 sales forecast. - AInvest
ARTIVION, INC. SEC 10-Q Report - TradingView
Artivion stock price target raised by Stifel to $40 on strong AMDS launch - Investing.com Nigeria
Stifel Raises Price Target for Artivion (AORT) to $40, Maintains Buy Rating | AORT Stock News - GuruFocus
Stifel Raises Artivion's PT to $40, Maintains Buy Rating - AInvest
Needham raises Artivion stock price target to $45 on growth acceleration - Investing.com Australia
Artivion Exceeds Q2 Revenue Estimates, Stock Jumps 13.1% - AInvest
Artivion stock price target raised to $41 from $35 at Canaccord on strong Q2 - Investing.com
1.74%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):